# A Double Blind Randomised Study of Lapatinib and Placebo in Metastatic TCC of the Urothelium

> **NCT00949455** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Queen Mary University of London** · enrollment: 204 (estimated)

## Conditions studied

- Bladder Cancer

## Interventions

- **DRUG:** lapatinib ditosylate
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT00949455
- **Lead sponsor:** Queen Mary University of London
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-03
- **Primary completion:** 2015-07
- **Final completion:** —
- **Target enrollment:** 204 (ESTIMATED)
- **Last updated:** 2015-04-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00949455

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00949455, "A Double Blind Randomised Study of Lapatinib and Placebo in Metastatic TCC of the Urothelium". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00949455. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*